Literature DB >> 15165000

Novel aspects of orbital fibroblast pathology.

T J Smith1.   

Abstract

Orbital fibroblasts exhibit a unique phenotype including exaggerated responses to proinflammatory cytokines. We hypothesize that the unusual susceptability of these fibroblasts to molecular cues underlies the involvement of the orbit in Graves' ophthalmopathy. A number of attributes of orbital fibroblasts are reviewed in this article. In addition, we have found IgG circulating in patients with Graves' disease that binds and activates the insulin-like growth factor-1 receptor displayed on fibroblasts from many anatomic regions. Activation of this receptor leads to the expression of T-cell chemoattractants. Thus, fibroblast activation, and the resulting T-cell trafficking to connective tissue in Graves' disease may be systemic. The consequences of lymphocyte-derived cytokine action may differ vastly in the orbit and other tissues manifesting clinically obvious disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165000     DOI: 10.1007/BF03345273

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  44 in total

1.  Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression.

Authors:  Rui Han; Shanli Tsui; Terry J Smith
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

2.  CD40 expression by human fibroblasts.

Authors:  K M Fries; G D Sempowski; A A Gaspari; T Blieden; R J Looney; R P Phipps
Journal:  Clin Immunol Immunopathol       Date:  1995-10

3.  Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.

Authors:  R W Valyasevi; D Z Erickson; D A Harteneck; C M Dutton; A E Heufelder; S C Jyonouchi; R S Bahn
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

4.  Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues.

Authors:  Patrizia Agretti; Luca Chiovato; Giuseppina De Marco; Claudio Marcocci; Barbara Mazzi; Stefano Sellari-Franceschini; Paolo Vitti; Aldo Pinchera; Massimo Tonacchera
Journal:  Eur J Endocrinol       Date:  2002-12       Impact factor: 6.664

5.  Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts.

Authors:  A Bell; A Gagnon; L Grunder; S J Parikh; T J Smith; A Sorisky
Journal:  Am J Physiol Cell Physiol       Date:  2000-08       Impact factor: 4.249

6.  Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.

Authors:  C M Rotella; R Zonefrati; R Toccafondi; W A Valente; L D Kohn
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

7.  Leukoregulin induces plasminogen activator inhibitor type 1 in human orbital fibroblasts.

Authors:  M G Hogg; C H Evans; T J Smith
Journal:  Am J Physiol       Date:  1995-08

8.  Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy.

Authors:  D R Weightman; P Perros; I H Sherif; P Kendall-Taylor
Journal:  Autoimmunity       Date:  1993       Impact factor: 2.815

9.  Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts.

Authors:  T J Smith; H S Wang; C H Evans
Journal:  Am J Physiol       Date:  1995-02

10.  Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts.

Authors:  T J Smith; R S Bahn; C A Gorman
Journal:  J Clin Endocrinol Metab       Date:  1989-11       Impact factor: 5.958

View more
  10 in total

1.  Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibers.

Authors:  Linda L Kusner; Andrew Young; Steven Tjoe; Patrick Leahy; Henry J Kaminski
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

2.  CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.

Authors:  Hao Wang; Li-Shuang Zhu; Jin-Wei Cheng; Ji-Ping Cai; You Li; Xiao-Ye Ma; Rui-Li Wei
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-11       Impact factor: 3.117

Review 3.  The origin of fibroblasts and mechanism of cardiac fibrosis.

Authors:  Guido Krenning; Elisabeth M Zeisberg; Raghu Kalluri
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

4.  Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Thyroid       Date:  2022-04       Impact factor: 6.506

5.  Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.

Authors:  Hao Wang; Stephen J Atkins; Roshini Fernando; Rui-Li Wei; Terry J Smith
Journal:  Endocrinology       Date:  2015-08-19       Impact factor: 4.736

Review 6.  Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy.

Authors:  Terry J Smith
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-01-31       Impact factor: 4.690

Review 7.  Graves' ophthalmopathy: state of the art and perspectives.

Authors:  L Bartalena; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

8.  PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy.

Authors:  Nupur Raychaudhuri; Raymond S Douglas; Terry J Smith
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

9.  Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease.

Authors:  Yan Xin; Fengyan Xu; Yuying Gao; Nivedita Bhatt; Jason Chamberlain; Saba Sile; Suzy Hammel; Robert J Holt; Srini Ramanathan
Journal:  Clin Pharmacokinet       Date:  2021-03-26       Impact factor: 6.447

10.  Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat.

Authors:  Iwona J Bujalska; Omar M Durrani; Joseph Abbott; Claire U Onyimba; Pamela Khosla; Areeb H Moosavi; Tristan T Q Reuser; Paul M Stewart; Jeremy W Tomlinson; Elizabeth A Walker; Saaeha Rauz
Journal:  J Endocrinol       Date:  2007-02       Impact factor: 4.286

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.